N(alpha)-carbobenzoxylysine-4-nitroanilide: RN given refers to (S)-isomer; from Vol 91, CA Chem Form Index [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 189751 |
| SCHEMBL ID | 1674876 |
| MeSH ID | M0083845 |
| Synonym |
|---|
| 70144-71-7 |
| cbz-lyspna |
| n(alpha)-carbobenzoxy-l-lysine-p-nitroanilide |
| carbamic acid, (5-amino-1-(((4-nitrophenyl)amino)carbonyl)pentyl)-, phenylmethyl ester, (s)- |
| n(alpha)-carbobenzoxylysine-p-nitroanilide |
| n(alpha)-carbobenzoxylysine-4-nitroanilide |
| n(alpha)-carbobenzoyllysine-para-nitroanilide |
| SCHEMBL1674876 |
| z-lys-pna |
| (s)-benzyl 6-amino-1-(4-nitrophenylamino)-1-oxohexan-2-ylcarbamate |
| n~2~-[(benzyloxy)(hydroxy)methylidene]-n-(4-nitrophenyl)lysinamide |
| DTXSID80990379 |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 5 (83.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.06) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 7 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||